Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

DIAGNOSIS

Has lupus anticoagulant testing had its day?

Nature Reviews Rheumatology volume 15, pages 324–325 (2019)Cite this article

Subjects

Antibodies against phosphatidylserine–prothrombin complexes (PS–PT) are one type of antiphospholipid antibody that is responsible for lupus anticoagulant activity. Anti-PS–PT antibodies are not currently included in the classification criteria for antiphospholipid syndrome (APS), but should they replace lupus anticoagulant testing to improve the diagnosis of APS?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Amengual, O. & Atsumi, T. Antiphospholipid syndrome, “the best prophet of the future”. Mod. Rheumatol. 28, 409–416 (2018).

    Article  CAS  Google Scholar 

  2. Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295–306 (2006).

    Article  CAS  Google Scholar 

  3. Sciascia, S. et al. Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphopholipid syndrome: a multicenter study. Front. Immunol. 10, 376 (2019).

    Article  Google Scholar 

  4. Atsumi, T. et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 43, 1982–1993 (2000).

    Article  CAS  Google Scholar 

  5. Galli, M. et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101, 1827–1832 (2003).

    Article  CAS  Google Scholar 

  6. Devreese, K. M. et al. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. J. Thromb. Haemost. 12, 792–795 (2014).

    Article  CAS  Google Scholar 

  7. Sciascia, S. et al. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb. Haemost. 111, 354–364 (2014).

    Article  CAS  Google Scholar 

  8. Amengual, O. et al. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study. Lupus 26, 266–276 (2017).

    Article  CAS  Google Scholar 

  9. Antovic, A. et al. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting. Thromb. Haemost. 117, 1700–1704 (2017).

    Article  Google Scholar 

  10. Nakamura, H. et al. First-line, non-criterial antiphospholipid antibody testing for the diagnosis of antiphospholipid syndrome in clinical practice: a combination of anti-β2 -glycoprotein I domain I and anti-phosphatidylserine/prothrombin complex antibodies tests. Arthritis Care Res. 70, 627–634 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    Yuichiro Fujieda & Tatsuya Atsumi

Authors
  1. Yuichiro Fujieda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tatsuya Atsumi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tatsuya Atsumi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujieda, Y., Atsumi, T. Has lupus anticoagulant testing had its day?. Nat Rev Rheumatol 15, 324–325 (2019). https://doi.org/10.1038/s41584-019-0218-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-019-0218-6

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing